Skip to main content
Premium Trial:

Request an Annual Quote

IP Update: Recent Patents Awarded to Quark, Somagenics, Bioneer, and More


Title: Diagnosis and Treatment of Cancers with microRNA Located in or Near Cancer-associated Chromosomal Features

Patent Number: 8,778,676

Filed: Aug. 21, 2013

Lead Inventor: Carlo Croce, Ohio State University (Microlin Bio)

Title: RNA Interference-mediating Small RNA Molecules

Patent Number: 8,778,902

Filed: July 13, 2010

Lead Inventor: Thomas Tuschl, Max Planck Institute

Title: Methods and Compositions for Treating Disease, Disorders, or Injury of the CNS

Patent Number: 8,778,904

Filed: Dec. 9, 2010

Lead Inventor: Elena Feinstein, Quark Pharmaceuticals

Title: Group of Nucleic Acid Fragments for Prevention of HIV Infection or AIDS and the Usage Thereof

Patent Number: 8,779,113

Filed: Jan. 10, 2011

Lead Inventor: Zhuwen Zhou, Beijing Solobio Genetechnology

Title: siRNA Conjugate and Preparation Method Thereof

Patent Number: 8,779,114

Filed: May 13, 2010

Lead Inventor: Bo Ram Han, Bioneer

Title: Short Hairpin RNAs for Inhibition of Gene Expression

Patent Number: 8,779,115

Filed: Aug. 22, 2012

Lead Inventor: Qing Ge, Somagenics

Title: siRNA-mediated Gene Silencing

Patent Number: 8,779,116

Filed: Nov. 5, 2012

Lead Inventor: Beverly Davidson, University of Iowa

Title: Gene Silencing

Patent Number: 8,779,236

Filed: July 23, 2009

Lead Inventor: David Baulcombe, Plant Bioscience

The Scan

Positive Framing of Genetic Studies Can Spark Mistrust Among Underrepresented Groups

Researchers in Human Genetics and Genomics Advances report that how researchers describe genomic studies may alienate potential participants.

Small Study of Gene Editing to Treat Sickle Cell Disease

In a Novartis-sponsored study in the New England Journal of Medicine, researchers found that a CRISPR-Cas9-based treatment targeting promoters of genes encoding fetal hemoglobin could reduce disease symptoms.

Gut Microbiome Changes Appear in Infants Before They Develop Eczema, Study Finds

Researchers report in mSystems that infants experienced an enrichment in Clostridium sensu stricto 1 and Finegoldia and a depletion of Bacteroides before developing eczema.

Acute Myeloid Leukemia Treatment Specificity Enhanced With Stem Cell Editing

A study in Nature suggests epitope editing in donor stem cells prior to bone marrow transplants can stave off toxicity when targeting acute myeloid leukemia with immunotherapy.